Загрузка...
LINKAGE TO PRIMARY CARE FOR PERSONS FIRST RECEIVING INJECTABLE NALTREXONE DURING INPATIENT OPIOID DETOXIFICATION
INTRODUCTION: Opioid use disorders commonly require ongoing medication-assisted treatment to reduce relapse following discharge from inpatient detoxification programs. Naltrexone, an opioid antagonist, is an increasingly popular treatment option in its once-monthly injectable form (XR-NTX). The aim...
Сохранить в:
| Опубликовано в: : | J Subst Abuse Treat |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4818184/ https://ncbi.nlm.nih.gov/pubmed/26920817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2016.01.007 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|